{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:01:28Z","timestamp":1772877688570,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12681-0","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T14:03:48Z","timestamp":1722348228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proximal femoral multiple myeloma pathological fractures, impending and actual fractures \u2013 a patient survival study"],"prefix":"10.1186","volume":"24","author":[{"given":"Oded","family":"Hershkovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojahed","family":"Sakhnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal","family":"Barkay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boaz","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"12681_CR1","first-page":"1503","volume":"91","author":"J Bickels","year":"2009","unstructured":"Bickels J, Dadia S, Lidar ZJJ. Surgical management of metastatic bone disease. 2009;91(6):1503\u201316.","journal-title":"Surgical management of metastatic bone disease"},{"key":"12681_CR2","doi-asserted-by":"crossref","unstructured":"Haidukewych GJ. Metastatic disease around the hip: maintaining quality of life.\u00a0J Bone Joint Surg Br. 2012;94(11_Supple_A):22\u201325.","DOI":"10.1302\/0301-620X.94B10.30509"},{"key":"12681_CR3","first-page":"464","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464\u201377.","journal-title":"Diagnosis and management of multiple myeloma: a review"},{"key":"12681_CR4","doi-asserted-by":"crossref","unstructured":"Shortt CP, Carty F, Murray JG. The role of whole-body imaging in the diagnosis, staging, and follow-up of multiple myeloma. in Seminars in musculoskeletal radiology. \u00a9 Thieme Medical Publishers; 2010.","DOI":"10.1055\/s-0030-1248705"},{"key":"12681_CR5","doi-asserted-by":"crossref","unstructured":"Kyle RA, et al. Review of 1027 patients with newly diagnosed multiple myeloma. in Mayo Clinic Proceedings. Elsevier; 2003.","DOI":"10.4065\/78.1.21"},{"key":"12681_CR6","doi-asserted-by":"crossref","unstructured":"Kyriakou C, et al. The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG).\u00a0Blood Cancer J. 2019;9(3):1\u201310.","DOI":"10.1038\/s41408-019-0187-7"},{"key":"12681_CR7","first-page":"256","volume":"249","author":"Mirels H.J.C.O.; Research R","year":"1989","unstructured":"Mirels H. Research, Metastatic Disease in Long Bones A Proposed Scoring System for Diagnosing Impending Pathologic Fractures.\u00a0Clin Orthop Relat Res. 1989;249:256\u201364.","journal-title":"Metastatic Disease in Long Bones A Proposed Scoring System for Diagnosing Impending Pathologic Fractures"},{"key":"12681_CR8","first-page":"S77","volume":"49","author":"A Angelini","year":"2018","unstructured":"Angelini A, et al. Treatment of pathologic fractures of the proximal femur.\u00a0Injury. 2018;49:S77\u2013S83.","journal-title":"Treatment of pathologic fractures of the proximal femur"},{"key":"12681_CR9","doi-asserted-by":"crossref","unstructured":"Mavrogenis AF, et al. Survival analysis of patients with femoral metastases.\u00a0J Surg Oncol. 2012;105(2):135\u201341.","DOI":"10.1002\/jso.22061"},{"key":"12681_CR10","doi-asserted-by":"crossref","unstructured":"Melton III LJ, et al. Fracture risk with multiple myeloma: a population\u2010based study.\u00a0J Bone Miner Res. 2005;20(3):487\u201393.","DOI":"10.1359\/JBMR.041131"},{"key":"12681_CR11","doi-asserted-by":"crossref","unstructured":"Lefaivre K, et al. Length of stay, mortality, morbidity and delay to surgery in hip fractures.\u00a0J Bone Joint Surg Br. 2009;91(7):922\u20137.","DOI":"10.1302\/0301-620X.91B7.22446"},{"key":"12681_CR12","doi-asserted-by":"crossref","unstructured":"Sanz-Reig J, et al. Prognostic factors and predictive model for in-hospital mortality following hip fractures in the elderly.\u00a0Chin J Traumatol. 2018;21(3):163\u20139.","DOI":"10.1016\/j.cjtee.2017.10.006"},{"key":"12681_CR13","doi-asserted-by":"crossref","unstructured":"Zhang X, et al. The biology of aging and cancer: frailty, inflammation, and immunity. Cancer J. 2017;23(4):201\u20135.","DOI":"10.1097\/00130404-201707000-00002"},{"key":"12681_CR14","doi-asserted-by":"publisher","unstructured":"Aunan JR, Cho WC, S\u00f8reide K. The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks. Aging Dis. 2017;8(5):628\u201342. https:\/\/doi.org\/10.14336\/ad.2017.0103.","DOI":"10.14336\/ad.2017.0103"},{"key":"12681_CR15","doi-asserted-by":"publisher","unstructured":"Boddapati V, et al. Risks and Complications After Arthroplasty for Pathological or Impending Pathological Fracture of the Hip. J Arthroplasty. 2021;36(6):2049\u201354.e5. https:\/\/doi.org\/10.1016\/j.arth.2021.02.004.","DOI":"10.1016\/j.arth.2021.02.004"},{"key":"12681_CR16","doi-asserted-by":"publisher","unstructured":"Roux C, et al. Percutaneous Fixation of Impending Fracture of the Hip. Tech Vasc Interv Radiol. 2022;25(1):100802. https:\/\/doi.org\/10.1016\/j.tvir.2022.100802.","DOI":"10.1016\/j.tvir.2022.100802"},{"key":"12681_CR17","doi-asserted-by":"publisher","unstructured":"Owen AR, et al. Outcomes of Intramedullary Nail Fixation for Metastatic Disease: Impending and Pathologic Fractures. Anticancer Res. 2022;42(2):919\u201322. https:\/\/doi.org\/10.21873\/anticanres.15550.","DOI":"10.21873\/anticanres.15550"},{"key":"12681_CR18","first-page":"302","volume":"52","author":"B Ristevski","year":"2009","unstructured":"Ristevski B, et al. Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome. Can J Surg. 2009;52(4):302.","journal-title":"Can J Surg"},{"key":"12681_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2106\/JBJS.16.00023","volume":"99","author":"A Aneja","year":"2017","unstructured":"Aneja A, et al. Thromboembolic disease in patients with metastatic femoral lesions: A comparison between prophylactic fixation and fracture fixation. JBJS. 2017;99(4):315\u201323.","journal-title":"JBJS"},{"key":"12681_CR20","first-page":"1067","volume":"105","author":"S Thorsteinsdottir","year":"2020","unstructured":"Thorsteinsdottir S, et al. Fractures and survival in multiple myeloma: results from a population-based study. 2020;105(4):1067.","journal-title":"Fractures and survival in multiple myeloma: results from a population-based study"},{"key":"12681_CR21","doi-asserted-by":"crossref","unstructured":"Malhotra K, et al. Successful nonsurgical treatment for highly unstable fracture subluxation of the spine secondary to myeloma.\u00a0Spine J. 2016;16(8):e547\u2013e551.","DOI":"10.1016\/j.spinee.2016.03.008"},{"key":"12681_CR22","first-page":"297","volume":"178","author":"BJ Gainor","year":"1983","unstructured":"Gainor BJ, Buchert P. Fracture healing in metastatic bone disease.\u00a0Clin Orthop Relat Res. 1983;178:297\u2013302.","journal-title":"Fracture healing in metastatic bone disease"},{"key":"12681_CR23","doi-asserted-by":"crossref","unstructured":"Wodajo F, Colman M, Getty P. AAOS Clinical Practice Guideline Summary: Treatment of Metastatic Carcinoma and Myeloma of the Femur.\u00a0J Am Acad Orthop Surg. 2023;31(3):e118\u2013e129.","DOI":"10.5435\/JAAOS-D-21-00888"},{"key":"12681_CR24","doi-asserted-by":"publisher","unstructured":"Gendi K, Hennessy D, Heiner J. The burden of metastatic disease of the femur on the Medicare system. SpringerPlus. 2016;5(1):1916. https:\/\/doi.org\/10.1186\/s40064-016-3572-8.","DOI":"10.1186\/s40064-016-3572-8"},{"key":"12681_CR25","first-page":"3","volume-title":"Bone metastases: epidemiology and societal effect","author":"RU Ashford","year":"2016","unstructured":"Ashford RU, Randall RL. Bone metastases: epidemiology and societal effect, in Metastatic Bone Disease. Springer; 2016. p. 3\u201311."},{"key":"12681_CR26","first-page":"3748","volume":"28","author":"D Axelrod","year":"2021","unstructured":"Axelrod D, Gazendam AM, Ghert M. The Surgical Management of Proximal Femoral Metastases: A Narrative Review.\u00a0Curr Oncol. 2021;28(5):3748\u201357.","journal-title":"The Surgical Management of Proximal Femoral Metastases: A Narrative Review"},{"key":"12681_CR27","doi-asserted-by":"crossref","unstructured":"Philipp TC, et al. Is there an association between prophylactic femur stabilization and survival in patients with metastatic bone disease?\u00a0Clin Orthop Relat Res. 2020;478(3):540.","DOI":"10.1097\/CORR.0000000000000803"},{"key":"12681_CR28","first-page":"412","volume":"45","author":"A Piccioli","year":"2014","unstructured":"Piccioli A, et al. Intramedullary nailing for treatment of pathologic femoral fractures due to metastases.\u00a0Injury. 2014;45(2):412\u20137.","journal-title":"Intramedullary nailing for treatment of pathologic femoral fractures due to metastases"},{"key":"12681_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.suronc.2013.02.008","volume":"22","author":"M Ratasvuori","year":"2013","unstructured":"Ratasvuori M, et al. Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis.\u00a0Surg Oncol. 2013;22(2):132\u20138.","journal-title":"Surg Oncol."},{"key":"12681_CR30","volume-title":"Orthopaedic management of metastatic bone disease; Mosby Incorporated","author":"KD Harrington","year":"1988","unstructured":"Harrington KD. Orthopaedic management of metastatic bone disease. Mosby Incorporated; 1988."},{"key":"12681_CR31","doi-asserted-by":"crossref","unstructured":"Jonas SC, et al. Current orthopaedic management of bony metastases in the proximal third of the femur.\u00a0Hip Int. 2017;27(1):1\u20137.","DOI":"10.5301\/hipint.5000497"},{"key":"12681_CR32","doi-asserted-by":"crossref","unstructured":"Padala SA, et al. Epidemiology, staging, and management of multiple myeloma.\u00a0Med Sci. 2021;9(1):3.","DOI":"10.3390\/medsci9010003"},{"key":"12681_CR33","doi-asserted-by":"crossref","unstructured":"Brenner H, Gondos A, Pulte DJB. Expected long-term survival of patients diagnosed with multiple myeloma in 2006\u20132010.\u00a0Blood. 2008;112(11):2368.","DOI":"10.1182\/blood.V112.11.2368.2368"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12681-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T14:04:23Z","timestamp":1722348263000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12681-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12681"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12681-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"2 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Sheba Medical Center, Tel Hashomer, affiliated to the Sackler School of Medicine, Tel Aviv, Israel.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No informed consent was required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"917"}}